Drug intelligence / Profile preview

CQ Max

Development stage
Unknown
Lead developer
Genspec Lifesciences
Modality
Small Molecules, Nanoparticles → Drug Delivery Systems
Administration
Oral
01

Overview

CQ Max is a nanocurcumin-based nutraceutical product developed by Genspec Lifesciences. It contains 125mg of nanocurcumin (equivalent to 40% curcuminoids) formulated as a water-soluble nanoparticle preparation. This delivery system is specifically designed to enhance the bioavailability and aqueous solubility of curcumin, a polyphenolic compound derived from turmeric (*Curcuma longa*) that typically exhibits poor oral absorption. Curcumin acts as a potent antioxidant and anti-inflammatory agent by modulating multiple molecular pathways, including the inhibition of pro-inflammatory transcription factors and enzymes. CQ Max is marketed as an oral syrup for general antioxidant and anti-inflammatory support and is positioned for the management of chronic conditions such as inflammation, pain, and metabolic disorders.

Brand names
CQ MaxCQ Max Syrup
Other names
NanocurcuminNanocurcumin 125mgNanocurcumin125mgNanocurcumin-125mg
02

Targets

PTGS2 (Prostaglandin-Endoperoxide Synthase 2)NF-κBTNFA (Tumor necrosis factor alpha (soluble))

Beyond the preview

Go deeper on CQ Max.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CQ Max.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call